Financial Performance - The company's operating revenue for the first half of 2022 was ¥422,680,454.62, representing a 5.09% increase compared to ¥402,226,485.31 in the same period last year[27]. - The net profit attributable to shareholders was ¥81,002,943.41, a decrease of 4.97% from ¥85,242,536.80 in the previous year[27]. - The net cash flow from operating activities was -¥180,420,968.06, showing a significant decline of 433.66% compared to -¥33,808,399.09 in the same period last year[27]. - The basic earnings per share decreased by 4.76% to ¥0.20 from ¥0.21 in the previous year[27]. - Total assets at the end of the reporting period were ¥2,327,352,451.15, down 4.39% from ¥2,434,188,058.80 at the end of the previous year[27]. - The net assets attributable to shareholders increased by 1.28% to ¥1,439,765,839.78 from ¥1,421,567,671.57 at the end of the previous year[27]. - The company reported a decrease of 7.09% in net profit after deducting non-recurring gains and losses, amounting to ¥72,487,145.87 compared to ¥78,021,457.31 in the previous year[27]. - The weighted average return on equity was 5.62%, down from 6.76% in the previous year, reflecting a decrease of 1.14%[27]. - The company reported a significant increase of 159.34% in other income, totaling ¥12,284,824.57, primarily due to increased government subsidies compared to ¥4,736,979.13 in the previous year[77]. - Revenue from the healthcare and medical insurance sector reached ¥222,638,208.83, a significant increase of 25.60% year-on-year[82]. - The digital government sector experienced a decline in revenue, totaling ¥161,723,197.25, down 15.44% from the previous year[82]. - Operating income from internet operations surged by 104.29%, amounting to ¥12,718,657.36[82]. - The gross profit margin for the software segment was 63.74%, with a year-on-year decrease of 3.34%[82]. - Direct labor costs increased by 33.01%, totaling ¥97,135,871.32, reflecting a significant rise in operational expenses[83]. Business Strategy and Development - The company maintained its overall business model focused on "deepening core operations, expanding around core, and innovating diversified revenue" during the reporting period[58]. - The company emphasized technological innovation and implemented a "centralized + intelligent" strategy, increasing investment in product research and development[58]. - The company is committed to high-priority investments in technological and business innovation, adhering to principles of "self-controllable and business-driven" technology innovation[62]. - The company is actively pursuing collaborations with large internet companies and industry investment platforms to expand its smart city ecosystem[58]. - The company plans to maintain its focus on core business while expanding through innovation and diversified revenue streams[124]. - The healthcare sector will be a key area of development, aiming to maintain leadership in domestic markets such as medical insurance and social security[124]. - The company will enhance its R&D and sales systems by optimizing a three-tier structure of "center + industry department + regional organization"[124]. - The company aims to improve its technology development capabilities by focusing on a core technology system and adapting to trends in domestic infrastructure[124]. Market and Competition - The company faces increased market competition risks due to the growing number of enterprises entering the livelihood information technology sector[115]. - The company is at risk of not keeping pace with policy changes in technology research and development, which could affect its competitive advantage[116]. - Rising operational costs due to increasing labor costs present a significant risk to the company's profitability[117]. - The company may face a decline in service charge standards for operation and maintenance services due to market expansion and increased competition[118]. - The company is exposed to risks from potential changes in government policies affecting the livelihood information technology sector, which could impact its operations[119]. Projects and Innovations - The company has developed a comprehensive blockchain BaaS platform to provide secure and reliable alliance chain environments for clients[75]. - The "MDLIFE" mobile application development platform enables rapid deployment of "Internet+" applications across various industries[74]. - The "DevOps" integrated development and operations platform enhances software lifecycle management and improves overall engineering efficiency[76]. - The company has established a low-code agile development framework, "Ta+3," which supports cloud-native deployment and microservices architecture[74]. - The company has launched a series of "Medical Insurance+" products, enhancing its ecological operational capabilities, with successful implementations in multiple medical institutions across provinces[44]. Shareholder and Capital Management - The company plans to replace self-owned funds with raised funds, with CNY 66,091.14 million replaced in 2022, including amounts from previous years[106]. - The total number of shares increased from 314,023,876 to 408,231,038 after a capital reserve conversion, with a cash dividend of 2.00 RMB per 10 shares distributed, totaling 62,804,775.20 RMB[177]. - Basic earnings per share decreased from 0.70 RMB to 0.54 RMB after the share changes, while diluted earnings per share also fell from 0.26 RMB to 0.20 RMB in the first half of 2022[180]. - The company has implemented a strategy to enhance shareholder value through cash dividends and share capital increases[177]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 26.29% of the shares, totaling 107,310,403 shares[187]. - The company reported no other related party transactions among the top shareholders[190]. Social Responsibility and Community Engagement - The company contributed over 116,870 yuan to poverty alleviation efforts through the purchase of products from impoverished regions[137]. - The "Village Doctor Pass" product has provided over 30 million medical insurance services, significantly reducing out-of-pocket expenses for rural patients[138].

Financial Performance - The company's revenue for Q1 2022 was ¥148,984,644.06, representing a 7.13% increase compared to ¥139,071,081.66 in the same period last year[3] - Net profit attributable to shareholders was ¥15,765,705.35, up 5.03% from ¥15,010,865.23 year-on-year[3] - The net profit excluding non-recurring gains and losses increased by 30.98% to ¥14,358,927.43 from ¥10,962,930.23 in the previous year[3] - Total operating revenue for the current period reached ¥148,984,644.06, an increase of 7.0% compared to ¥139,071,081.66 in the previous period[27] - Net profit for the current period was ¥13,602,485.72, representing a 6.5% increase from ¥12,773,980.25 in the previous period[30] - Basic and diluted earnings per share remained stable at ¥0.05 for both periods[33] Cash Flow - The net cash flow from operating activities was -¥160,805,851.47, a decrease of 43.63% compared to -¥111,955,512.13 in the same period last year[3] - Cash inflow from operating activities totaled ¥127,446,795.36, a decrease of 23.6% from ¥166,763,173.43 in the prior period[34] - The net cash flow from operating activities was -$160.81 million, compared to -$111.96 million in the previous period, indicating a decline in operational performance[37] - Cash outflow from investing activities totaled $72.59 million, a significant decrease from $224.54 million in the prior period, reflecting reduced investment expenditures[37] - The net cash flow from investing activities improved to $44.20 million, compared to -$56.03 million previously, suggesting better investment returns[37] - The company reported a net decrease in cash and cash equivalents of -$118.68 million, an improvement from -$167.98 million in the prior period[37] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,323,174,026.15, down 4.56% from ¥2,434,188,058.80 at the end of the previous year[3] - The company's cash and cash equivalents decreased to RMB 580,645,542.84 from RMB 699,841,253.57, representing a decline of about 17%[17] - Accounts receivable decreased to RMB 395,037,567.64 from RMB 417,436,576.42, indicating a reduction of approximately 5.1%[20] - Inventory increased to RMB 307,988,647.38 from RMB 246,098,947.89, showing an increase of around 25.3%[20] - The total liabilities decreased to RMB 759,280,333.09 from RMB 883,896,851.46, a reduction of about 14.1%[23] - The company's equity attributable to shareholders increased by 1.11% to ¥1,437,333,376.92 from ¥1,421,567,671.57 at the end of the previous year[3] Expenses - Total operating costs amounted to ¥134,047,572.98, up 6.7% from ¥125,551,566.91 in the prior period[27] - Research and development expenses were ¥17,193,668.13, down 12.5% from ¥19,652,354.90 in the previous period[27] - Sales expenses increased to ¥30,205,003.47, up 12.5% from ¥26,786,415.03 in the prior period[27] - Management expenses rose to ¥31,742,679.93, compared to ¥27,831,980.23 in the previous period, reflecting a 14.0% increase[27] - Other income decreased to ¥2,236,977.84 from ¥3,296,619.25 in the previous period[27] - Cash paid to employees was $150.11 million, up from $120.92 million, indicating increased labor costs[37] - Cash paid for taxes decreased to $31.18 million from $41.18 million, reflecting a reduction in tax liabilities[37] Investments and Development - The company reported a significant increase in development expenditures, rising 63.21% to ¥81,803,543.88 from ¥50,122,420.86[7] - Investment income surged by 110.31% to ¥2,177,278.92 compared to ¥1,035,254.92 in the previous year[7] - The company experienced a 178.88% increase in net cash flow from investing activities, amounting to ¥44,196,568.49 compared to -¥56,027,672.35 in the same period last year[7] - The company won a bid for a software project with a total amount of RMB 106,200,000, which was confirmed on February 15, 2022[16] - The company is currently planning to expand its market presence and explore new strategies, although specific details were not disclosed in the report[16] Shareholder Information - The largest shareholder, Sichuan Jiuyuan Investment Holding Group, holds 26.29% of the company's shares, indicating a significant ownership stake[16] - The company did not report any new strategies or significant market expansions during the quarter[3] - The company did not conduct an audit for the first quarter report, which may affect the reliability of the financial data presented[40]

Financial Performance - The company's operating revenue for 2021 was CNY 1,305,907,210.66, representing a 13.21% increase compared to CNY 1,153,540,813.37 in 2020[24] - The net profit attributable to shareholders for 2021 was CNY 218,502,273.04, up 17.09% from CNY 186,612,666.30 in 2020[24] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 202,824,949.31, reflecting a 20.07% increase from CNY 168,922,764.27 in 2020[24] - The basic earnings per share for 2021 was CNY 0.70, an increase of 18.64% compared to CNY 0.59 in 2020[24] - The total assets at the end of 2021 were CNY 2,434,188,058.80, a 9.53% increase from CNY 2,222,397,947.21 at the end of 2020[24] - The net assets attributable to shareholders at the end of 2021 were CNY 1,421,567,671.57, up 13.76% from CNY 1,249,614,316.59 at the end of 2020[24] - The company's cash flow from operating activities for 2021 was CNY 202,423,221.77, a decrease of 2.53% from CNY 207,671,998.11 in 2020[24] - The weighted average return on net assets for 2021 was 16.46%, compared to 15.54% in 2020[24] Revenue and Profit Growth - The company's total revenue for Q4 reached ¥675,867,541.90, with a year-on-year increase of 13.8% compared to Q3[28] - Net profit attributable to shareholders for Q4 was ¥97,474,824.49, reflecting a significant increase from ¥35,784,911.75 in Q3[28] - The net cash flow from operating activities in Q4 was ¥247,033,262.16, a substantial recovery from a negative cash flow of ¥10,801,641.30 in Q3[28] - The software business revenue grew by 29.24%, contributing significantly to the overall profit increase[66] - Revenue from the healthcare and medical insurance sector was CNY 596,049,433.52, accounting for 45.64% of total revenue, with a growth of 25.05%[66] Investment and R&D - Research and development expenses rose by 7.51% to CNY 164,763,611.08 in 2021, compared to CNY 153,250,099.25 in 2020[84] - The number of R&D personnel increased by 60.25% from 712 in 2020 to 1,141 in 2021, with a notable rise in younger employees under 30 years old by 127.19%[90] - R&D investment amounted to ¥208,780,628.52 in 2021, representing an 11.84% increase from ¥186,679,637.10 in 2020, while the R&D investment as a percentage of operating revenue decreased slightly to 15.99%[90] - The company capitalized ¥51,203,788.24 of its R&D expenses in 2021, a significant increase of 57.61% compared to ¥32,488,584.61 in 2020, with the capitalization rate rising to 24.53%[90] Market Expansion and Strategic Focus - The company plans to focus on the development of smart hospitals and healthcare information platforms, aligning with national health strategies[37] - The company aims to further expand its medical insurance market and enhance cooperation with industry stakeholders to support the "Healthy China" initiative[50] - The company is actively pursuing strategic partnerships and potential acquisitions to bolster its market position and product offerings[154] - The company plans to expand its market presence and invest in new product development, focusing on software solutions and technology advancements[154] Risks and Challenges - The company acknowledges potential risks in future operations and encourages investors to pay attention to investment risks[5] - The company anticipates risks from intensified market competition as more players enter the growing field of livelihood information technology[136] - There is a risk that the company's technology development may not keep pace with policy changes, potentially impacting its competitive edge[136] - Rising operational costs, particularly in labor, pose a significant challenge to the company's profitability[136] Governance and Management - The company has established a complete organizational structure that operates independently, with all departments functioning according to the company's regulations[144] - The company has a performance assessment system for senior management, which is based on the completion of annual operational goals and individual work performance[181] - The board of directors has undergone changes, with the appointment of new members to enhance governance and strategic direction[153] - The company has appointed independent directors and supervisors across various non-listed companies, ensuring governance and oversight[180] Future Outlook - The future outlook remains positive, with projected growth in revenue and market share driven by new technology initiatives and product launches[154] - The company provided a future outlook with a revenue guidance of 1.5 billion RMB for the next fiscal year, indicating a growth target of 25%[167] - The company is investing 200 million RMB in R&D for new technologies aimed at enhancing software performance and security[167] - New product launches included a software solution that is expected to capture a 10% market share within the first year of release[167]

Financial Performance - The company's revenue for Q3 2021 was ¥227,813,183.45, representing a 21.42% increase year-over-year[4] - Net profit attributable to shareholders for Q3 2021 was ¥35,784,911.75, up 16.11% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses was ¥32,789,129.43, reflecting a 36.36% increase year-over-year[4] - Total operating revenue for the current period reached ¥630,039,668.76, an increase of 26.4% compared to ¥498,348,115.50 in the previous period[30] - Net profit for the current period was ¥115,976,400.39, up 20.0% from ¥96,623,650.75 in the same period last year[36] - Basic and diluted earnings per share for the current period were both ¥0.3854, compared to ¥0.2821 in the previous period, reflecting a growth of 36.7%[36] - The total comprehensive income attributable to shareholders of the parent company was ¥121,027,448.55, up 36.5% from ¥88,596,197.22 in the previous period[36] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to ¥2,256,175,103.06, a 1.52% increase from the end of the previous year[6] - The total current assets were RMB 1.75 billion, down from RMB 1.82 billion in the previous period[23] - The company's cash and cash equivalents were RMB 345.44 million, a decrease from RMB 729.98 million in the previous period[20] - Total liabilities decreased to ¥827,707,035.53 from ¥852,102,698.67, a reduction of approximately 2.9%[29] - Total assets amounted to approximately $2.22 billion, a slight decrease from $2.23 billion in the previous period[50] - Current liabilities were approximately $795.08 million, compared to $799.92 million previously[50] - Total liabilities reached approximately $852.10 million, a decrease from $861.12 million[50] Shareholder Information - The equity attributable to shareholders increased by 5.92% year-over-year, reaching ¥1,323,538,183.74[6] - The total number of common shareholders at the end of the reporting period was 16,655[15] - Sichuan Jiuyuan Investment Holding Group Co., Ltd. holds 26.29% of the shares, making it the largest shareholder with 82,546,464 shares[15] - The total equity attributable to shareholders of the parent company increased to ¥1,323,538,183.74, up 5.9% from ¥1,249,614,316.59[29] Research and Development - The company reported a significant increase in research and development expenses, totaling ¥64,812,664.78, which is a 51.66% increase compared to the same period last year[11] - Research and development expenses increased to ¥64,812,664.78, representing a rise of 51.6% from ¥42,734,990.02 in the previous period[30] - The company has invested RMB 119.89 million in development expenditures, significantly up from RMB 49.48 million in the previous period[23] Cash Flow - Cash flow from operating activities showed a net outflow of ¥44,610,040.39, a decrease of 759.07% year-over-year[11] - The net cash flow from operating activities for the current period was -44,610,040.39 RMB, compared to -5,192,834.99 RMB in the previous period, indicating a decline in operational cash flow[40] - Total cash inflow from operating activities was 664,969,611.16 RMB, up from 587,408,299.62 RMB in the previous period, reflecting a growth of approximately 13.2%[40] - Cash outflow from operating activities totaled 709,579,651.55 RMB, compared to 592,601,134.61 RMB in the previous period, representing an increase of about 19.7%[40] - The cash flow from investment activities showed a net outflow of -285,470,777.51 RMB, worsening from -139,108,401.30 RMB in the previous period[40] - Cash inflow from investment activities was 550,001,957.32 RMB, compared to 386,016,410.96 RMB in the previous period, marking an increase of approximately 42.4%[40] - The total cash outflow from investment activities was 835,472,734.83 RMB, significantly higher than 525,124,812.26 RMB in the previous period, indicating a rise of about 59.2%[40] - The net cash flow from financing activities was -54,659,100.05 RMB, compared to -46,792,553.80 RMB in the previous period, showing a decline in financing cash flow[40] - The ending balance of cash and cash equivalents was 335,964,013.52 RMB, down from 596,977,381.26 RMB in the previous period, reflecting a decrease of approximately 43.7%[40] Other Information - The company experienced a 100% decrease in trading financial assets, dropping to ¥0.00 due to the maturity of financial products[11] - The company has ongoing plans for potential changes in its actual controller due to shareholding adjustments by its largest shareholder[18] - The company completed the purchase of an office building by its wholly-owned subsidiary, Sichuan Jiuyuan Yinhai Changhui Software Co., Ltd.[19] - The company reported a goodwill of approximately $34.76 million[50] - Deferred tax assets were approximately $28.14 million[50] - The company has a total of approximately $119.37 million in intangible assets[50] - The company has implemented new leasing standards since January 1, 2021, affecting the financial statements[50] - The third quarter report was not audited[53]

Financial Performance - The company's operating revenue for the first half of 2021 was ¥402,226,485.31, representing a 29.45% increase compared to ¥310,721,129.44 in the same period last year[25]. - The net profit attributable to shareholders of the listed company was ¥85,242,536.80, up 47.54% from ¥57,775,935.64 in the previous year[25]. - The net profit after deducting non-recurring gains and losses was ¥78,021,457.31, reflecting a 47.76% increase from ¥52,802,308.92 year-on-year[25]. - The basic earnings per share increased to ¥0.27, a 50.00% rise compared to ¥0.18 in the same period last year[25]. - The weighted average return on equity was 6.76%, up from 5.09% in the previous year, an increase of 1.67%[25]. - The gross profit margin improved, with operating profit reaching ¥94,252,325.26, up 41.64% from the previous year[66]. - The company reported a total investment income of ¥3,523,671.56, accounting for 3.71% of total profit[76]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,211,853,394.83, a slight decrease of 0.47% from ¥2,222,397,947.21 at the end of the previous year[25]. - Cash and cash equivalents at the end of the reporting period amounted to ¥408,403,493.25, representing 18.46% of total assets, a decrease of 14.39% compared to the previous year[80]. - Accounts receivable totaled ¥327,672,039.87, accounting for 14.81% of total assets, with a slight decrease of 0.33% year-over-year[80]. - Inventory increased to ¥326,053,147.96, making up 14.74% of total assets, reflecting a growth of 2.95% due to the expansion of the company's operations[80]. - Contract assets rose to ¥33,882,176.69, representing 1.53% of total assets, an increase of 0.74% attributed to projects with unfulfilled payment conditions[80]. - Current liabilities totaled ¥740,479,257.27, down from ¥795,079,165.93, indicating a reduction of about 6.9%[198]. - Total liabilities decreased to ¥807,110,914.69 from ¥852,102,698.67, showing a decline of around 5.3%[198]. Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of ¥33,808,399.09, a 65.35% reduction from a net outflow of ¥97,569,918.44 in the previous year[25]. - The company reported a net cash outflow from operating activities of ¥33,808,399.09, an improvement of 65.35% compared to the previous year[65]. - The investment activities resulted in a significant cash outflow of ¥236,744,374.65, primarily due to increased expenditures on financial products and fixed assets[65]. Market and Business Development - The company participated in the construction of new generation medical insurance information platforms in 17 provinces, winning bids in 7 provinces, including 5 new projects during the reporting period[37]. - The company has expanded its medical health information market to cover 14 provinces, providing services to over 1,000 hospitals[39]. - The company achieved a continuous increase in market share in the human resources and social security sector, winning multiple major projects including the social security centralized project in Guizhou and the employment service management system in Sichuan[42]. - The company has covered 56 cities in 17 provinces for housing provident fund management, with significant progress in cities like Chongqing and Tianjin[43]. - The company has successfully implemented the "Smart Union" project for labor unions, achieving notable progress in related industry projects[44]. - The company has developed specialized products for market supervision, winning bids for major projects including the food safety supervision system and the vaccine traceability system[45]. - The company has launched a comprehensive solution for veteran services, successfully implementing projects in Sichuan and Chengdu[46]. - The company is actively exploring new paths for urban governance and data resource system construction[48]. - The company is actively participating in the construction of a credit city, collaborating with government departments to develop the "Chengdu Jiazi Credit Score" to support the city's national social credit system[51]. Research and Development - Research and development investment increased by 27.90% to ¥91,116,379.59, reflecting the company's commitment to enhancing its technological capabilities[65]. - The company has made significant technological advancements in cloud computing, big data, artificial intelligence, and other areas, improving product quality and production efficiency[52]. - The company has established a comprehensive technology product system, including platforms for mobile application development and big data, supporting industry product development[52]. Risks and Challenges - The company faces risks from intensified market competition and the need to keep up with rapid policy changes in the public service information sector[95]. - The company faces increasing operational cost risks due to rising labor costs, which are expected to continue as average wage levels rise across society[97]. - There is a potential risk from changes in government policies affecting the livelihood information technology sector, which could impact the company's operations negatively[99]. - Rapid growth has led to management risks, as the complexity of the organizational structure increases with asset and personnel expansion[100]. - The company is facing human resource risks due to intensified competition for high-quality talent, which could affect future business development if not managed properly[100]. Corporate Governance and Social Responsibility - The company emphasizes its commitment to social responsibility and aims to improve product quality and service levels while maintaining good relationships with partners[113]. - The company emphasizes employee rights and development, adhering to labor laws and providing various benefits such as statutory holidays and performance evaluations[115]. - In 2021, the company contributed a total of 336,500 CNY towards poverty alleviation through purchasing products from impoverished regions[119]. - The company actively organizes cultural and training activities, including competitions and skill training to enhance employee morale and professional skills[116]. - The company has established a dedicated training department to provide IT, management, and psychological training for employees[116]. Shareholder Information - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 26.29% of the shares, totaling 82,546,464 shares[171]. - The second-largest shareholder, Sichuan Science City Ruifeng Group Co., Ltd., holds 12.02% of the shares, totaling 37,755,536 shares[171]. - The total number of shareholders at the end of the reporting period was 20,169, with 5% or more shareholders being 10[171]. - The report indicates that 12,380,219 shares held by executives were unlocked during the year, with an increase of 73,770 shares due to executive purchases in the first half of the year[164]. - The company has a total of 41,855,845 restricted shares, with 35,204,095 shares released during the reporting period[170]. Miscellaneous - The company has not engaged in any significant related party transactions during the reporting period[134]. - The company has not reported any non-compliance with external guarantees during the reporting period[127]. - The financial report for the first half of 2021 was not audited[190]. - The company did not issue any preferred shares during the reporting period[183].

Financial Performance - The company's operating revenue for Q1 2021 was ¥139,071,081.66, representing a 28.96% increase compared to ¥107,836,726.26 in the same period last year[8] - Net profit attributable to shareholders for Q1 2021 was ¥15,010,865.23, a 46.46% increase from ¥10,249,017.29 year-on-year[8] - The net profit after deducting non-recurring gains and losses was ¥10,962,930.23, up 23.30% from ¥8,891,230.08 in the previous year[8] - Basic earnings per share for Q1 2021 were ¥0.05, down 16.67% from ¥0.06 in the same period last year[8] - Diluted earnings per share were also ¥0.05, a decrease of 16.67% compared to ¥0.06 year-on-year[8] - The weighted average return on equity was 1.19%, slightly up from 1.17% in the previous year[8] - Total operating revenue for the first quarter was CNY 139,071,081.66, an increase of 28.4% compared to CNY 107,836,726.26 in the previous year[56] - Net profit for the period reached CNY 12,773,980.25, representing a 40.5% increase from CNY 9,096,610.86 in the same period last year[62] - The total comprehensive income for the current period was ¥24,353,737.55, compared to ¥14,653,334.75 in the previous period, reflecting a growth of approximately 66.5%[73] Cash Flow - The net cash flow from operating activities was -¥111,955,512.13, an improvement of 6.22% compared to -¥119,383,011.74 in the same period last year[8] - Cash flow from operating activities totaled ¥166,763,173.43, compared to ¥100,903,703.80 in the previous period, showing an increase of approximately 65.2%[78] - The net cash flow from operating activities was negative at CNY -49,666,557.88, an improvement compared to CNY -78,088,251.58 in the prior period[81] - Cash outflow from investment activities totaled CNY 214,653,559.61, compared to CNY 132,866,771.26 in the previous period, indicating a 61.5% increase[84] - The company's cash inflow from operating activities was CNY 109,619,314.07, a significant increase from CNY 54,376,889.79 in the previous period, representing a growth of approximately 101%[81] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,172,462,232.00, a decrease of 2.25% from ¥2,222,397,947.21 at the end of the previous year[8] - The total assets decreased to CNY 1,885,319,785.77 from CNY 1,898,077,451.79, a decline of 0.6%[56] - The total liabilities of the company were approximately 789 million yuan, down from 852 million yuan at the end of 2020[46] - Total liabilities decreased to CNY 730,913,843.72 from CNY 768,025,247.29, a reduction of 4.8%[56] - The company's total equity reached approximately 1.38 billion yuan, an increase from 1.37 billion yuan at the end of 2020[49] - The company's total equity increased to CNY 1,154,405,942.05 from CNY 1,130,052,204.50, reflecting a growth of 2.2%[56] Investments and Expenses - Investment income surged by 808.39% to CNY 1,035,255 from CNY 113,966, driven by increased returns from financial products[19] - Research and development expenses increased by 64.27% to CNY 19,652,355 from CNY 11,963,603 due to higher spending in the research phase[19] - Total operating costs amounted to CNY 125,551,566.91, up from CNY 93,614,558.63, reflecting a year-over-year increase of 34.1%[59] - The company reported a significant increase in net investment income to CNY 1,035,254.92 from CNY 113,965.89, marking a substantial growth[59] Projects and Future Outlook - The "Medical Insurance Convenience Service Platform" project has achieved a cumulative investment progress of 12.57% as of March 31, 2021[26] - The company is planning to complete the "Medical Insurance Fund Actuarial and Governance Solutions" project by December 31, 2021, with a cumulative investment of CNY 1,267.65 million[26] - The company reported a net profit forecast for the first half of 2021, indicating potential losses or significant changes compared to the same period last year[30] Miscellaneous - The company has engaged in entrusted wealth management with a total amount of 30 million yuan and an outstanding balance of 25 million yuan[31] - The report for the first quarter of 2021 was not audited[98] - The company implemented a new leasing standard starting January 1, 2021, which resulted in adjustments to the financial statements without affecting comparative period information[90]

Financial Performance - The company's operating revenue for 2020 was ¥1,153,540,813.37, representing a 13.50% increase compared to ¥1,016,378,796.96 in 2019[25] - The net profit attributable to shareholders for 2020 was ¥186,612,666.30, which is a 15.55% increase from ¥161,493,339.26 in 2019[25] - The net cash flow from operating activities was ¥207,671,998.11, showing a 21.67% increase compared to ¥170,688,672.64 in 2019[25] - The basic earnings per share for 2020 was ¥0.59, up 15.69% from ¥0.51 in 2019[25] - Total assets at the end of 2020 were ¥2,222,397,947.21, an increase of 8.65% from ¥2,045,383,667.36 at the end of 2019[28] - The net assets attributable to shareholders at the end of 2020 were ¥1,249,614,316.59, reflecting a 9.83% increase from ¥1,137,804,187.93 at the end of 2019[28] - The company reported a weighted average return on equity of 15.54% for 2020, compared to 15.00% in 2019[25] - The net profit after deducting non-recurring gains and losses for 2020 was ¥168,922,764.27, which is a 15.87% increase from ¥145,789,629.47 in 2019[25] Cash Flow and Investments - The total cash inflow from operating activities in 2020 was ¥1,105,936,975.25, an increase of 11.63% compared to ¥990,673,937.68 in 2019[98] - The net cash flow from investment activities was -¥217,316,684.19, a significant increase of 1,145.79% compared to -¥17,459,861.16 in 2019[98] - The company's cash and cash equivalents decreased by ¥67,367,239.88, marking a 318.78% decline from an increase of ¥30,792,234.36 in the previous year[99] - The company has a total of CNY 39,447.67 million in unused raised funds, which are stored in a dedicated bank account and used for short-term financial products[113] - The company reported a total of CNY 11,399,178.44 in interest income from raised funds during the year[116] Revenue Breakdown - Revenue from the healthcare sector was ¥476,651,420.99, accounting for 41.32% of total revenue, with a growth of 23.66% year-over-year[67] - Revenue from smart city and digital government services was ¥623,406,703.36, making up 54.04% of total revenue, with a year-over-year increase of 10.44%[67] - The operating service segment generated ¥425,689,355.30, which is 36.90% of total revenue, reflecting a growth of 35.67% year-over-year[70] - The software product line contributed ¥521,515,941.98, accounting for 45.21% of total revenue, with an increase of 11.76% year-over-year[70] Research and Development - Research and development expenses increased by 79.48% to CNY 153,250,099.25, reflecting the company's focus on expanding its research capabilities[86] - The number of R&D personnel rose by 8.87% to 712, representing 31.46% of the total workforce[88] - The company's R&D investment reached CNY 186,679,637.10, which is 16.18% of its operating revenue, up from 12.09% the previous year[88] - The company has invested significantly in research and development, focusing on technology platforms and digital governance, with several projects in the development stage[94] Market and Operational Strategy - The company has successfully participated in the construction of new generation medical insurance information platforms in 12 provinces, enhancing its market presence in the healthcare sector[41] - The company has upgraded and developed various healthcare products, covering over 1,000 hospitals across 14 provinces, demonstrating its commitment to healthcare information systems[42] - The company has expanded its digital governance solutions, winning major contracts in social security and employment systems, including projects in Guizhou and Hubei provinces[43] - The company aims to focus on strategic directions such as healthcare insurance, digital governance, and smart cities, while enhancing its market influence in various information technology sectors[128] Risks and Challenges - The company acknowledges potential risks in future operations and encourages investors to be aware of investment risks[6] - The company faces increasing market competition as more enterprises enter the livelihood informationization sector, posing a risk to its market position[130] - The company is at risk of not keeping pace with policy changes affecting its technology research and development, which could weaken its competitive advantage[133] - Rising operational costs, particularly in labor, are expected to exert pressure on the company's profitability due to increasing average wage levels[134] Dividend Distribution - The company plans to distribute a cash dividend of ¥1.50 per 10 shares, with a total of 314,023,876 shares as the base[7] - The cash dividend amount for 2020 was ¥47,103,581.40, representing 25.24% of the net profit attributable to ordinary shareholders[151] - The total distributable profit for the year was ¥447,251,596.47, with the cash dividend accounting for 100% of the profit distribution[154] - The company has committed to maintaining a minimum cash dividend ratio of 20% during profit distribution[154] Accounting and Compliance - The company has no significant discrepancies between financial reports prepared under international accounting standards and those under Chinese accounting standards[30] - The company has implemented significant accounting policy changes, including the adoption of the new revenue recognition standard, which resulted in a decrease of 32,328,857.52 CNY in accounts receivable[172] - The company reported a total of 545,526,515.15 CNY in contract liabilities as of December 31, 2020, reflecting a significant adjustment due to the new accounting standards[172] - The company has not experienced any non-operating fund occupation by controlling shareholders or related parties during the reporting period[169]

Financial Performance - Operating revenue for the reporting period was ¥187,626,986.06, representing a year-on-year growth of 21.27%[8] - Net profit attributable to shareholders was ¥30,820,261.58, up 38.07% year-on-year[8] - Basic earnings per share for the reporting period was ¥0.0981, reflecting a growth of 37.97% year-on-year[8] - The company reported a decrease of 3.37% in net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date period[8] - Total operating revenue for the third quarter reached ¥187,626,986.06, an increase of 20.5% compared to ¥154,720,350.88 in the previous year[54] - Net profit for the quarter was ¥37,320,464.15, compared to ¥26,550,098.14 in the same period last year, representing a growth of 40.5%[60] - The company's total revenue for the current period reached ¥127,495,016.45, an increase of 8.4% compared to ¥117,844,432.48 in the previous period[64] - Operating profit for the current period was ¥26,327,116.18, up from ¥12,911,059.55 in the previous period, reflecting a significant improvement[67] - Net profit for the current period was ¥24,413,155.40, compared to ¥17,705,039.40 in the previous period, indicating a growth of 38.1%[67] - The company’s net profit attributable to shareholders was ¥88,596,197.22, compared to ¥84,234,721.82 in the previous period, showing an increase of 5.6%[74] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,113,570,589.52, an increase of 3.33% compared to the end of the previous year[8] - The company's total assets increased to ¥1,784,329,388.29, up from ¥1,725,817,113.52, marking a growth of 3.4%[54] - The total liabilities increased to CNY 840,979,750.19 from CNY 796,342,662.38, reflecting a growth of about 5.6%[44] - Total liabilities rose to ¥706,814,503.24, compared to ¥661,217,852.62, indicating an increase of 6.9%[54] - The total assets decreased to 2,045,383,667.36 from 2,104,903,693.35[101] - Total liabilities reached ¥796,342,662.38, reflecting a decrease of ¥85,801,288.62[108] - Total current liabilities amounted to ¥746,589,826.15, a decrease of ¥85,801,288.62 compared to the previous period[108] - Total non-current liabilities were ¥49,752,836.23, remaining unchanged from the previous period[108] Cash Flow - Net cash flow from operating activities was ¥92,377,083.45, a significant increase of 252.75% compared to the same period last year[8] - Cash flow from operating activities showed a net outflow of approximately ¥5.19 million, an improvement from a net outflow of ¥123.35 million in the previous year[88] - Total cash inflow from operating activities was 402,182,804.32, compared to 336,484,367.33 in the previous period[94] - Cash paid to employees decreased to 193,360,596.45 from 206,016,719.99[94] - The ending balance of cash and cash equivalents decreased to 349,163,006.06 from 474,793,155.02[97] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,732[12] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 26.29% of the shares[12] - The company's equity attributable to shareholders reached CNY 1,157,744,554.08, compared to CNY 1,137,804,187.93 at the end of 2019, marking an increase of approximately 1.75%[47] Research and Development - Development expenses surged by 148.56% to CNY 103,764,895.47, indicating increased R&D spending[19] - Research and development expenses for the quarter were ¥15,114,819.90, slightly up from ¥14,296,172.07, indicating a focus on innovation[57] - The company has invested CNY 103,764,895.47 in development expenditures, significantly up from CNY 41,746,676.65 in the previous year[41] - Research and development expenses decreased to ¥8,738,222.21 from ¥15,341,619.47, a reduction of 43.1%[64] Government Subsidies and Other Income - The company received government subsidies amounting to ¥13,237,774.28 during the reporting period[8] - Other income increased by 97.70% to CNY 13,237,774.28, primarily from government subsidies[19] - The company reported an increase in other income to approximately ¥5.72 million, compared to ¥3.11 million in the previous year, representing an increase of 83.5%[82] Future Outlook - The company plans to expand its market presence and invest in new technologies to drive future growth[60] - The company has indicated a positive outlook for the next quarter, expecting continued revenue growth driven by new product launches and market expansion strategies[60]

Financial Performance - The company's operating revenue for the first half of 2020 was ¥310,721,129.44, a decrease of 8.82% compared to ¥340,771,740.51 in the same period last year[22]. - The net profit attributable to shareholders was ¥57,775,935.64, down 6.68% from ¥61,913,186.07 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥52,802,308.92, a decline of 12.22% compared to ¥60,155,176.82 in the same period last year[22]. - The basic earnings per share were ¥0.18, a decrease of 10.00% from ¥0.20 in the same period last year[22]. - The diluted earnings per share were also ¥0.18, reflecting a 10.00% decline compared to ¥0.20 in the previous year[22]. - The weighted average return on equity was 5.09%, down from 6.10% in the same period last year, a decrease of 1.01%[22]. - Revenue for the first half of 2020 was CNY 310.72 million, representing a year-on-year decline of 8.82% due to the impact of pandemic control measures[60]. - Net profit attributable to shareholders for the same period was CNY 57.78 million, down 6.68% year-on-year[59]. - The company reported a total revenue of 250.16 million with a market pricing increase of 4.81%[144]. Cash Flow and Assets - The net cash flow from operating activities improved to -¥97,569,918.44, a 34.75% increase from -¥149,533,175.89 in the previous year[22]. - The total assets at the end of the reporting period were ¥2,027,976,263.92, a decrease of 0.85% from ¥2,045,383,667.36 at the end of the previous year[22]. - The net assets attributable to shareholders were ¥1,126,924,292.50, down 0.96% from ¥1,137,804,187.93 at the end of the previous year[22]. - Cash and cash equivalents increased by CNY 16,290,810.33, primarily due to the maturity of financial products[66]. - The company’s investment activities generated a net cash inflow of CNY 159.95 million, an increase of 87.14% due to the maturity of financial products[60]. - The company’s total inventory increased by 19.62% to CNY 397,821,330.35[75]. - Fixed assets increased by 5.02% to CNY 101,720,963.24, indicating a stable investment in long-term assets[75]. Strategic Initiatives - The company serves over 90,000 institutions and 600 million individuals across 25 provinces and over 100 cities in China[34]. - The company is involved in the construction of the National Medical Insurance Bureau's medical security information platform, with key components entering the acceptance phase[35]. - The company has launched a series of products in value-based healthcare, focusing on big data applications in hospital management and medical research[36]. - The company has initiated the construction of smart health elderly care service platforms in Fuzhou and has made progress on various civil affairs projects[40]. - The company continues to focus on three strategic directions: medical insurance, digital government, and smart cities, aiming to become a leading enterprise in smart living[106]. Competition and Market Position - The company faces intense competition but leverages its established market foundation and capabilities in the smart civil service sector[46]. - The company is positioned at the core of national strategies like "Digital China" and "Healthy China," benefiting from accelerated development due to the COVID-19 pandemic[45]. - The company anticipates potential declines in service fees for its operational services due to market expansion and increased competition[114]. Research and Development - Research and development expenses increased by 52.78% to CNY 71.24 million, driven by increased investment in R&D projects[60]. - The company has enhanced its industry understanding and innovation capabilities through major projects in healthcare and smart city sectors[49]. - The company plans to enhance innovation investment and optimize innovation management to strengthen its industry development, particularly in the medical health sector[110]. Risks and Challenges - The company faces risks from intensified market competition as more enterprises enter the civil informationization sector, which could challenge its competitive advantages[111]. - The company is at risk of technological challenges if it fails to keep pace with policy changes affecting its products and services, which are closely tied to government regulations[112]. - Rising operational costs due to increasing labor expenses pose a significant risk to the company's profitability[113]. - The company acknowledges the risk of losing core technical personnel, which could adversely affect its R&D and operational capabilities[119]. Shareholder Information - The company held its first extraordinary general meeting of shareholders in 2020 with a participation rate of 50.37% on January 17, 2020[122]. - The annual general meeting of shareholders in 2019 had a participation rate of 50.53% on May 22, 2020[122]. - The company plans not to distribute cash dividends or issue bonus shares for the half-year period[123]. - The company’s major shareholders include Sichuan Jiuyuan Investment Holding Group Co., Ltd. (26.29%) and Sichuan Science City Ruifeng Group Co., Ltd. (12.02%) with significant changes in their holdings during the reporting period[180]. - The company reported a decrease in the number of restricted shares, with a total of 41,746,645 restricted shares at the end of the period, down from 34,324,454[179].

Financial Performance - The company's operating revenue for Q1 2020 was ¥107,836,726.26, a decrease of 14.59% compared to ¥126,257,210.73 in the same period last year[8]. - Net profit attributable to shareholders was ¥10,249,017.29, down 26.92% from ¥14,024,418.08 year-on-year[8]. - The company's net profit for Q1 2020 was CNY 9,096,610.86, a decrease of 35.78% compared to CNY 14,164,963.64 in Q1 2019[20]. - Net profit for the current period was ¥9,096,610.86, down 35.8% from ¥14,164,963.64 in the previous period[58]. - The total profit for the period was 16,019,007.31, a decrease of 14.5% compared to 18,739,644.27 in the previous period[65]. - Net profit for the period was 14,653,334.75, down from 15,436,764.39, representing a decline of 5.1%[68]. - Operating profit was reported at 18,003,198.26, slightly lower than 18,704,581.96 from the previous period[65]. - The company's total comprehensive income for the current period was ¥9,096,610.86, compared to ¥14,164,963.64 in the previous period[60]. - The total comprehensive income for the period was 14,653,334.75, compared to 15,436,764.39 in the previous period[68]. Cash Flow - The net cash flow from operating activities was -¥119,383,011.74, representing a decline of 28.44% compared to -¥92,947,202.29 in the previous year[8]. - Cash flow from operating activities was 100,903,703.80, a decrease from 109,948,107.65 in the previous period[69]. - The company experienced a 106.60% decrease in cash flow from investing activities, with a net outflow of CNY -6,359,761.50 compared to CNY 96,416,685.29 in Q1 2019[23]. - Cash flow from investing activities showed a net outflow of 6,359,761.50, contrasting with a net inflow of 96,416,685.29 in the previous period[72]. - Cash flow from financing activities resulted in a net outflow of 1,232,000.00, compared to 225,000.00 in the previous period[75]. - The company reported a decrease in cash and cash equivalents, ending the period with 661,871,270.11, down from 760,523,419.99[75]. - The net cash inflow from investment activities was approximately CNY 2.06 million, a significant decrease from CNY 99.07 million in the previous period[79]. - The total cash and cash equivalents at the end of the period were CNY 428 million, down from CNY 558 million at the beginning of the period, reflecting a net decrease of CNY 76 million[79]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,968,725,733.44, down 3.75% from ¥2,045,383,667.36 at the end of the previous year[8]. - Total assets decreased from ¥2,045,383,667.36 to ¥1,968,725,733.44, a decline of approximately 3.8%[44]. - Non-current assets increased from ¥366,392,575.35 to ¥373,891,719.03, an increase of about 2.3%[44]. - Current liabilities decreased from ¥746,589,826.15 to ¥659,163,783.31, a reduction of approximately 11.7%[42]. - Total liabilities decreased from ¥796,342,662.38 to ¥707,971,320.51, a decline of approximately 11.1%[42]. - Total liabilities decreased to ¥600,489,791.08 from ¥661,217,852.62, a reduction of 9.2%[52]. - The total liabilities decreased to CNY 793 million from CNY 796 million, showing a reduction of CNY 3 million[86]. - Total equity increased from ¥1,249,041,004.98 to ¥1,260,754,412.93, an increase of about 0.9%[45]. - The company's equity attributable to shareholders increased to CNY 1.14 billion, up from CNY 1.13 billion, reflecting an increase of CNY 3.18 million[86]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,098[13]. - Basic earnings per share decreased by 25.00% to ¥0.06 from ¥0.08 in the same period last year[8]. - Earnings per share (basic and diluted) for the current period were both ¥0.06, compared to ¥0.08 in the previous period[61]. - Basic and diluted earnings per share were both 0.07, down from 0.09 in the previous period[68]. Government Support and Donations - The company received government subsidies amounting to ¥2,756,476.59 during the reporting period[8]. - Other income increased significantly by 240.74% to CNY 2,756,476.59, mainly due to increased government subsidies[20]. - The company reported a significant impact from donations of ¥2,000,000 to the Hubei Charity Federation during the pandemic[8]. Adjustments and Compliance - The company adjusted its financial statements according to the new revenue recognition standards, impacting accounts receivable by a decrease of approximately 53.29 million[92]. - The adjustment also resulted in a decrease of inventory by about 1.08 million and an increase in contract assets by approximately 54.65 million[92]. - The company reported an increase in undistributed profits by approximately 1.90 million due to the adjustments made[92]. - The first quarter report for 2020 was not audited, indicating a preliminary financial status[93]. - The company is focused on compliance with the revised accounting standards, which may affect future financial reporting and performance metrics[92].